Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
6,999,586
-
Total 13F shares
-
6,948,962
-
Share change
-
+2,212,928
-
Total reported value
-
$84,695,343
-
Price per share
-
$12.19
-
Number of holders
-
47
-
Value change
-
+$29,084,194
-
Number of buys
-
29
-
Number of sells
-
8
Institutional Holders of TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) as of Q4 2025
As of 31 Dec 2025,
TENAX THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (TENX) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,948,962 shares.
The largest 10 holders included
Ikarian Capital, LLC, MORGAN STANLEY, PERCEPTIVE ADVISORS LLC, Siren, L.L.C., Point72 Asset Management, L.P., RTW INVESTMENTS, LP, BOOTHBAY FUND MANAGEMENT, LLC, BVF INC/IL, MILLENNIUM MANAGEMENT LLC, and MARSHALL WACE, LLP.
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.